Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Oct 1;160(10):1068-1075.
doi: 10.1001/jamasurg.2025.3102.

Prehabilitation With Exercise and Nutrition to Reduce Morbidity of Major Hepatectomy in Patients With Sarcopenia: The PREHEP Randomized Clinical Trial

Giammauro Berardi  1 , Alessandro Cucchetti  2 , Marco Colasanti  1 , Marco Angrisani  1 , Giovanni Moschetta  1 , Davide Chiappori  1 , Alice Marini  1 , Giulio Antonelli  3 , Stefano Ferretti  1 , Roberto Luca Meniconi  1 , Nicola Guglielmo  1 , Germano Mariano  1 , Sofia Usai  1 , Giuseppe Maria Ettorre  1
Affiliations
Randomized Controlled Trial

Prehabilitation With Exercise and Nutrition to Reduce Morbidity of Major Hepatectomy in Patients With Sarcopenia: The PREHEP Randomized Clinical Trial

Giammauro Berardi et al. JAMA Surg. .

Abstract

Importance: Sarcopenia is an emerging predictor of complications after liver surgery. Strategies to mitigate its impact are crucial to improving postoperative outcomes.

Objective: To determine whether a 6-week multimodal prehabilitation program combining physical exercise and nutritional support reduces postoperative morbidity in patients with sarcopenia who are undergoing major hepatectomy.

Design, setting, and participants: This study is a single-center, open-label, randomized clinical trial conducted from April 2022 to January 2025. Adult patients with sarcopenia scheduled for major liver resection and requiring future liver remnant hypertrophy were randomized (1:1) to receive either structured prehabilitation or standard care. The trial was conducted in a tertiary hepatobiliary referral center in Italy. Enrolled adult patients had radiologically and functionally confirmed sarcopenia. Most patients underwent portal vein embolization and right hepatectomy.

Interventions: The intervention group received a 6-week program while awaiting future liver remnant hypertrophy including daily walking, supervised biweekly in-hospital exercise, and branched-chain amino acid and immune nutritional supplementation. The control group received standard perioperative care.

Main outcomes and measures: The primary outcome was 90-day postoperative morbidity, assessed by Clavien-Dindo classification.

Results: A total of 70 adult patients with radiologically and functionally confirmed sarcopenia were enrolled, and 60 (median [IQR] age, 69 [63-75] years; 32 male [53.3%]) were included in the final analysis. Most patients (52 [86.7%]) underwent portal vein embolization, and 63 (88.3%) underwent right hepatectomy. Overall morbidity was significantly lower in the prehabilitation group (4 of 30 [13.3%] vs 15 of 30 [50%]; odds ratio, 0.15; 95% CI, 0.04-0.55; P = .004), with an absolute risk reduction of 36.7% and number needed to treat of 3. All major complications occurred in the control group (6 of 30 [20%]; d = 0.40; P = .02). Muscle mass and strength improved significantly only in the prehabilitation arm.

Conclusions and relevance: Results of this randomized clinical trial reveal that a 6-week structured prehabilitation program significantly reduced postoperative morbidity in patients with sarcopenia undergoing major liver resection. These findings support integrating exercise and nutritional interventions into preoperative care for high-risk surgical patients to improve surgical outcomes.

Trial registration: ClinicalTrials.gov Identifier: NCT05281211.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Comment in

References

    1. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191(1):38-46. doi: 10.1016/S1072-7515(00)00261-1 - DOI - PubMed
    1. Kamiyama T, Nakanishi K, Yokoo H, et al. Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. J Am Coll Surg. 2010;211(4):443-449. doi: 10.1016/j.jamcollsurg.2010.06.005 - DOI - PubMed
    1. Virani S, Michaelson JS, Hutter MM, et al. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1284-1292. doi: 10.1016/j.jamcollsurg.2007.02.067 - DOI - PubMed
    1. Franken LC, Schreuder AM, Roos E, et al. Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: a systematic review and meta-analysis. Surgery. 2019;165(5):918-928. doi: 10.1016/j.surg.2019.01.010 - DOI - PubMed
    1. Oussoultzoglou E, Jaeck D, Addeo P, et al. Prediction of mortality rate after major hepatectomy in patients without cirrhosis. Arch Surg. 2010;145(11):1075-1081. doi: 10.1001/archsurg.2010.225 - DOI - PubMed

Publication types

Associated data